Researchers at the University of Illinois Urbana-Champaign report that a tiny four-fingered “hand” made from one piece of DNA folded can detect COVID-19 with high sensitivity and speed. It can also prevent viral particles entering cells in order to cause infection. The NanoGripper nanorobotic arm could also be programmed for interaction with other viruses, or for recognition of cell surface markers to deliver targeted drugs, for example for cancer treatment.
The researchers, led by Xing wang, a bioengineering professor and chemistry professor at U. of I. describe their progress in Science Robotics. The researchers developed the NanoGripper, a nanostructure with four bendable finger and palm. All of this is folded out of a single DNA piece. The DNA scaffold is designed to have three joints per finger. Each finger also has a joint like the human finger.
“We wanted to make a soft material, nanoscale robot with grabbing functions that never have been seen before, to interact with cells, viruses and other molecules for biomedical applications,” Wang said. “We are using DNA for its structural properties. It is strong, flexible and programmable. Yet even in the DNA origami field, this is novel in terms of the design principle. We fold one long strand of DNA back and forth to make all of the elements, both the static and moving pieces, in one step.”
In the fingers, there are DNA aptamers which have been programmed specifically to bind molecular targets – the spike protein from the COVID-19 virus for the first application – and cause the fingers to wrap around that target. The NanoGripper, which is located on the other side of the wrist, can be attached to surfaces or larger complexes for biomedical purposes such as drug delivery or sensing.
In order to create a COVID-19 sensor, Wang’s team collaborated with Brian Cunningham of the Illinois Electrical and Computer Engineering Department, a professor who is an expert in biosensing. The NanoGripper was coupled with a platform of photonic crystal sensors to produce a 30-minute COVID-19 rapid test that matches the accuracy and sensitivity levels of gold-standard molecular tests performed in hospitals.
These tests are much more precise than home tests, but they take much longer. Cunningham stated. Wang stated that the NanoGripper, in addition to being used for diagnostics, could also be applied in prevention medicine, by preventing viruses from infecting and entering cells. Researchers found that adding NanoGrippers to cells that had been exposed to COVID-19 caused multiple grippers to wrap around COVID-19. The researchers found that the NanoGrippers prevented the spike proteins of the virus from interfacing with the receptors located on the surface of the cells, thus preventing the infection.
“It would be very difficult to apply it after a person is infected, but there’s a way we could use it as a preventive therapeutic,” Wang said. Wang stated that the NanoGripper can be easily engineered to attack other viruses such as influenza or HIV. Wang also envisions the NaoGripper being used for targeted drug distribution. The fingers, for example, could be programmed in order to recognize specific cancer markers and the grippers, to deliver cancer-fighting treatment directly to target cells.
“This approach has bigger potential than the few examples we demonstrated in this work,” Wang said. This work was supported by the National Institutes of Health (NIH) and National Science Foundation (19659011). Wang and Cunningham have affiliations with the Carl R. Woese Institute for Genomic Biology and Holonyak Micro and Nanotechnology Lab, both at U. of I.